Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Platelets|March 8, 2017
Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligandI C Moschonas, T F Kellici, T Mavromoustakos, et al.Current Medical Research and Opinion|June 3, 2008
The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemiaE S Nakou, T D Filippatos, M Georgoula, et al.Expert Opinion on Pharmacotherapy|June 24, 2008
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patientsE Nakou, T D Filippatos, E N Liberopoulos, et al.European Journal of Clinical Investigation|February 13, 2001
Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplastyJ Goudevenos, A D Tselepis, M P Vini, et al.Atherosclerosis|August 17, 2006
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndromeT D Filippatos, I F Gazi, E N Liberopoulos, et al.Expert Opinion on Pharmacotherapy|December 2, 2008
The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemiaE S Nakou, T D Filippatos, D N Kiortsis, et al.International Journal of Clinical Practice|August 18, 2012
Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndromeA P Agouridis, M S Kostapanos, V Tsimihodimos, et al.Cardiovascular Research|October 28, 1999
Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapyA D Tselepis, J A Goudevenos, A P Tambaki, et al.Lipids|October 29, 2008
Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndromeK G Lagos, T D Filippatos, V Tsimihodimos, et al.Current Medical Research and Opinion|May 23, 2002
Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromesL K Michalis, A P Tambaki, C S Katsouras, et al.Pageof 6